Integra LifeSciences Holdings Corporation [IART] Q1 2024 Earnings Conference Call May 6, 2024 8:30 AM ET Company Participants Jan De Witte – President & CEOLea Knight – CFOChris Ward – IR Conference Call Participants Vik Chopra – Wells FargoSteve Lichtman – OppenheimerKristen Stewart – C.L. King & AssociatesRobbie Marcus – J.P. MorganMatt Taylor – JefferiesRyan…
Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET Company Participants Mark Wilterding – SVP & IRBernard Zovighian – CEOScott Ullem – CFODaveen Chopra – Global Leader of TMTTLarry Wood – Group President of TAVR and Surgical Structural HeartKatie Szyman – Global Leader of Critical Care Conference Call Participants…
Integra LifeSciences Holdings Corporation. (NASDAQ:IART) Q4 2023 Earnings Conference Call February 28, 2024 8:30 AM ET Company Participants Christopher Ward – Senior Director of Investor Relations Jan De Witte – President and Chief Executive Officer Lea Knight – Chief Financial Officer Conference Call Participants Vik Chopra – Wells Fargo Kristen Stewart – CL King Ryan…
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Conference Call February 22, 2024 5:00 PM ET Company Participants Deb Hart – Investor Relations Trey Martin – Chief Executive Officer Kevin Herde – Chief Financial Officer Drew Burch – President of Nucleic Acid Production Conference Call Participants Matt Larew – William Blair Justin Bowers – Deutsche…
sanjeri Good judgment comes from experience, and experience comes from bad judgment.”― Rita Mae Brown. Today, we take our second look at Maravai LifeSciences Holdings, Inc. (MRVI). When we first highlighted this small biopharma concern in March, the company was the subject of some speculative buyout speculation and also navigating through somewhat of a “Covid…
Matteo Colombo Investment Briefing In my June publication covering Integra LifeSciences Holdings Corporation (NASDAQ:IART) I outlined the case to how it was not an investment-grade company based on a number of outcomes at its Boston manufacturing facility. I’ll re-hash the salient points on this today but the fact is multiple uncertainties remain on the company’s…
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Michael Miller – Rx Communications, IR Paul Hickey – President and CEO Tom Stankovich – CFO Christine Ren-Fielding – Member, ReShape Scientific Advisory Board Conference Call Participants Anthony Vendetti – Maxim Operator Good afternoon, and thank you for…